Navigation Links
Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Date:5/24/2011

peline, 2011 63

Table 42: Retinal Vein Occlusion Therapeutics, Regeneron Pharmaceuticals, Retinal Vein Occlusion Pipeline, 2011 63

Table 43: Regeneron Pharmaceuticals Deals, 2009-2011 64

Table 44: Retinal Vein Occlusion Therapeutics, Global, Deals, 2008-2011 66

1.2 List of Figures

Figure 1: Eye Diagram Depicting Normal and Effected Blood Vessels 6

Figure 2: Recent Onset Central Retinal Vein Occlusion, Showing Extensive Hemorrhages in the Posterior Pole and Creating the "Blood and Thunder Appearance" 7

Figure 3: Peripheral Fundus View, Showing Hemorrhages Extending All Over the Fundus 7

Figure 4: Fluorescein Angiograph Showing Hypofluorescence Due to Hemorrhages in Retina 9

Figure 5: Treatment Algorithm for RVO 9

Figure 6: Preferred Treatment for Macular Edema Following BRVO 11

Figure 7: Preferred Treatment for Cystoid Macular Edema Following CRVO 11

Figure 8: Retinal Vein Occlusion Therapeutics Market, Global, Revenue ($m), 2005–2010 13

Figure 9: Retinal Vein Occlusion Therapeutics Market, Global, Forecast ($m), 2010–2017 14

Figure 10: Retinal Vein Occlusion Therapeutics Market, The US, Revenue ($m), 2005-2010 15

Figure 11: Retinal Vein Occlusion Therapeutics Market, The US, Forecast ($m), 2010–2017 16

Figure 12: Retinal Vein Occlusion Therapeutics Market, France, Revenue ($m), 2005–2010 17

Figure 13: Retinal Vein Occlusion Therapeutics Market, France, Forecast ($m), 2010–2017 18

Figure 14: Retinal Vein Occlusion Therapeutics Market, Germany, Revenue ($m), 2005–2010 19

Figure 15: Retinal Vein Occlusion Therapeutics Market, Germany, Forecast ($m), 2010–2017 20

Figure 16: Retinal Vein Occlusion Therapeutics Market, Italy, Revenue ($m), 2005–2010 21

Figure 17: Retinal Vein Occlusion Therapeutics Market, Italy, Forecast ($m), 2010–2017 22

Figure 18: Retinal V
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
2. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
3. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
4. Reportlinker Adds Advanced Digital Medical Equipment Products Market
5. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
6. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
7. Reportlinker Adds Orphan Drugs in Asia 2011
8. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
9. Reportlinker Adds The Outlook for Medical Devices in South East Asia
10. Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
11. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Regado Biosciences, Inc. (Nasdaq: ... the Phase 3 clinical development of Revolixys™ Kit (previously ... system, today announced that it will hold a conference ... 2014, at 8:30 a.m. EDT to discuss its second ... Interested participants and investors may access the conference call ...
(Date:7/29/2014)... , July 29, 2014  Alexza Pharmaceuticals, Inc. ... is participating in two healthcare conferences during the third ... the Morgan Stanley Global Healthcare 2014 Conference.  Alexza,s corporate ... Conference.  The details on each event are below: ... August 11, 2014 in Boston , ...
(Date:7/29/2014)... , July 29, 2014  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... financial results for the fiscal third quarter 2014 after ... The Company will host a conference call ... a.m. Central Time (10 a.m. Eastern Time). Investors may ...
Breaking Medicine Technology:Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 2Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights 3Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results 2
... Five Posters Scheduled for the 2008 Annual Meeting ... Vision and Ophthalmology (ARVO), IRVINE, Calif., Feb. ... announced today the acceptance of an abstract,describing the ... 0.09% therapy in combination with Lucentis(R) (ranibizumab,injection) in ...
... Flawed policies and,bad decisions at the FDA have contributed ... now take an average of one billion dollars and,require ... prevented the,availability of many promising treatment options, resulting in ... cost of medical,treatment in the United States., It,s ...
Cached Medicine Technology:ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 2ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 3ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 4ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 5Cancer Cure Coalition Proposes Major Changes at the FDA 2Cancer Cure Coalition Proposes Major Changes at the FDA 3
(Date:7/29/2014)... SC (PRWEB) July 29, 2014 During his ... L. Bruce, DMD & Associates, has had a steady stream ... about dentistry. These students have now gone on to dental ... practices, proving that the shadowing program helps college students find ... Dr. Bruce has given them the chance to see a ...
(Date:7/29/2014)... of Medicine researchers have made an important advancement ... potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA). ... seen a steady rise in the incidence of ... making the need for a vaccine critical. Successful ... to prevent disease, and the VCU team has ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Bret ... LLP ’s Boise office, has been appointed to the ... Greater Idaho. , Busacker is an experienced business attorney ... matters. He advises clients on a wide spectrum of ... plan administration, compliance, and governance concerns. His clients include ...
(Date:7/29/2014)... cancer is to surgically remove the tumor. The Achilles ... may fail to extract the entire tumor, leading to ... at the University of Pennsylvania have established a new ... the patient, increasing the likelihood of a positive outcome. ... in cancerous tissues much more so than normal tissues. ...
(Date:7/29/2014)... Helping people recover from the debilitating effects ... requires deep knowledge of neurophysiology as well as effective ... outcomes has been the primary focus of research by ... joined the NJIT faculty more than a decade ago. ... funding from sources such as the National Institutes of ...
Breaking Medicine News(10 mins):Health News:Arthur Bruce Dental Helps College Students 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 2Health News:Researchers take steps toward development of a vaccine against tick-transmitted disease 3Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4
... ... accident, persuades jury that defendants were 100% responsible for client’s accident. , ... New York (Lexis Nexis) November 30, 2009 -- ... who was injured at a New York City construction site in 2004., , ,The case, ...
... , CLEVELAND, Ohio, November 30 ... simulation systems, in collaboration,with GORE Medical Products will be ... at the upcoming ICCA Meeting in Frankfurt,Germany. , ... the world,s first medical,simulator to enable clinicians to create ...
... CHICAGO Elastography is an effective, convenient technique ... cancerous breast lesions from benign results, according to ... meeting of the Radiological Society of North America ... often use ultrasound to obtain additional information. However, ...
... ... Dentistry (AGD) announces that Aria Irvani, DDS, of Orange county CA, received the Mastership ... dental education.,To accomplish this, Dr. Irvani completed 1,100 hours of approved continuing dental education ... techniques. , ...
... For well-being, a $1,300 round of treatment equals a ... (HealthDay News) -- Psychological therapy may be much more ... or winning a lottery prize, suggests an English study. ... provided information about their mental well-being and found that ...
... Nov. 28 Get ready for advanced visualization to ... Siemens introduces syngo. via(1) at ... North America (RSNA) from November 29 to December 3 at McCormick Place ... syngo. via , Siemens, new imaging ...
Cached Medicine News:Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: